Abstract:Nonresolving inflammation in the intestine predisposes individuals to the development of colitis-associated cancer (CAC). Inflammasomes are thought to mediate intestinal homeostasis, and their dysregulation contributes to inflammatory bowel diseases and CAC. However, few agents have been reported to reduce CAC by targeting inflammasomes. Here we show that the small molecule andrographolide (Andro) protects mice against azoxymethane/dextran sulfate sodium-induced colon carcinogenesis through inhibiting the NLRP3 inflammasome. Administration of Andro significantly attenuated colitis progression and tumor burden. Andro also inhibited NLRP3 inflammasome activation in macrophages both in vivo and in vitro, as indicated by reduced expression of cleaved CASP1, disruption of NLRP3-PYCARD-CASP1 complex assembly, and lower IL1B secretion. Importantly, Andro was found to trigger mitophagy in macrophages, leading to a reversed mitochondrial membrane potential collapse, which in turn inactivated the NLRP3 inflammasome. Moreover, downregulation of the PIK3CA-AKT1-MTOR-RPS6KB1 pathway accounted for Andro-induced autophagy. Finally, Andro-driven inhibition of the NLRP3 inflammasome and amelioration of murine models for colitis and CAC were significantly blocked by BECN1 knockdown, or by various autophagy inhibitors. Taken together, our findings demonstrate that mitophagy-mediated NLRP3 inflammasome inhibition by Andro is responsible for the prevention of CAC. Our data may help guide decisions regarding the use of Andro in patients with inflammatory bowel diseases, which ultimately reduces the risk of CAC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Whether NLRP3 inflammasome inhibition mediated by small - molecule - induced mitophagy can prevent colitis - associated cancer (CAC)**. Specifically, the study explored the mechanism of action of natural small molecules and Andrographolide (Andro) in preventing a mouse colon cancer model induced by azoxymethane (AOM) and dextran sulfate sodium (DSS). The study found that Andro can inhibit the activation of NLRP3 inflammasome by inducing mitophagy, thereby reducing the inflammatory response and further preventing colitis - associated cancer. ### Main research contents: 1. **The influence of Andro on colitis - associated tumorigenesis**: - The study used the AOM - DSS mouse model to evaluate the influence of Andro on colitis - associated tumorigenesis. - The results showed that Andro significantly reduced the weight loss of mice, decreased the number and size of tumors, and alleviated the tumor burden. 2. **The influence of Andro on inflammation**: - The study found that Andro significantly reduced the inflammation level in mice in the AOM - DSS model, including reducing the phosphorylation of NF - κB, decreasing the expression of pro - inflammatory cytokines (such as TNF - α, IL - 17A, IL - 6) and inhibiting the expression of COX2. 3. **The influence of Andro on DSS - induced experimental colitis**: - The study further verified the anti - inflammatory effect of Andro in the DSS - induced experimental colitis model. The results showed that Andro significantly alleviated weight loss, disease activity index, colon shortening and pathological changes. 4. **The inhibitory effect of Andro on NLRP3 inflammasome**: - The study found that Andro could significantly inhibit the activation of NLRP3 inflammasome both in vivo and in vitro, and reduce the activation of CASP1 and the secretion of IL - 1β. 5. **The mechanism of Andro - induced mitophagy**: - The study indicated that Andro triggered mitophagy by inhibiting the PIK3CA - AKT1 - MTOR - RPS6KB1 signaling pathway, preventing the collapse of mitochondrial membrane potential, thereby inhibiting the activation of NLRP3 inflammasome. ### Conclusion: This study revealed the mechanism by which Andro effectively prevents colitis - associated cancer by inhibiting the activation of NLRP3 inflammasome through inducing mitophagy. These findings may be helpful in guiding clinical decision - making, especially in using Andro to treat patients with inflammatory bowel disease, and ultimately reducing their risk of developing colitis - associated cancer.

Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer

Andrographolide-triggered mitophagy-mediated NLRP3 inflammasome inhibition accounts for the prevention of colitis-associated cancer (TUM7P.919)

Mitophagy-mediated NLRP3 inflammasome inhibition by andrographolide contributes to the prevention of colitis-associated cancer (1052.3)

Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis.

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome

Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission

Mkp-1 is required for chemopreventive activity of butylated hydroxyanisole and resveratrol against colitis-associated colon tumorigenesis.

Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?

The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer

Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation

High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism

Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer

The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies

Protective effect of Andrographolide on 5-Fu induced intestinal mucositis by regulating p38 MAPK signaling pathway

Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice

Alpha-1 Antitrypsin Inhibits Tumorigenesis and Progression of Colitis-Associated Colon Cancer through Suppression of Inflammatory Neutrophil-Activated Serine Proteases and IGFBP-3 Proteolysis

Andrographolide Sulfonate Ameliorates Chronic Colitis Induced by TNBS in Mice Via Decreasing Inflammation and Fibrosis.

Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles

Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer